Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: SINOPHARM(01099) the Revenue is 159.59 B (+5.19%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
159.59B5.19%
----
----
Revenue
ActualEstimateUnit: HKD
qf
EBIT
ActualEstimateUnit: HKD
qf
Net income
ActualEstimateUnit: HKD
qf
EPS
ActualEstimateUnit: HKD
qf